Autoimmune patients suffer a variety of comorbidities and often require extra care—here’s how the costs of that care can be reduced.
Here are five things managed care executives should know about the proposed plan.
Four things you need to know about the Trump Administration’s proposed regs.
There has been an increase in the number of people with autoimmune diseases. Here’s what you should know about them.
A chief executive officer must have a more diverse team to address the rising complexity and velocity of healthcare. Here are four positions that managed care organizations may want to seriously consider.
Experts predict what oncology care will look like a decade from now.
Individuals with immune-mediated diseases, such as psoriasis, are at higher risk for having other immune-mediated diseases. Here’s how psoriasis can lead to other conditions, and the associated costs.
Managing psoriasis can be difficult for a variety of reasons. Here’s a look at the top six challenges that experts identified.
Healthcare experts detail three policies that MCOs should keep a close eye on.
What these healthcare industry disruptors are, and how they could impact cost and quality of care.